Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: A longitudinal population-based cohort study

American Journal of Epidemiology

Volumn 176, Issue 3, 2012, Pages 253-260

  Vanhala, Mauno ^a,e   Saltevo, Juha ^a   Soininen, Pasi ^b,c   Kautiainen, Hannu ^a   Kangas, Antti J ^b   Ala Korpela, Mika ^b,c,d   Mäntyselkä, Pekka ^e  

^a CENTRAL FINLAND CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

cohort studies; fatty acids, omega 3; fatty acids, omega 6; Finland; metabolic syndrome X; polyunsaturated fatty acids

Indexed keywords

OMEGA 6 FATTY ACID;

ALCOHOL; BODY MASS; COHORT ANALYSIS; FATTY ACID; LIPID; METABOLISM; NUCLEAR MAGNETIC RESONANCE; SATURATION; SERUM; SMOKING; VEGETABLE OIL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; FINLAND; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SMOKING;

AGE FACTORS; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; DIETARY FATS, UNSATURATED; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FINLAND; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX FACTORS;

EID: 84864419893     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr504     Document Type: Article

References (37)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9486):1415-1428.
2. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17(4):319-326.
3. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Coordinating Committee of the National Cholesterol Education Program. J Am Coll Cardiol. 2004;44(3):720-732.
4. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr. 2004; 23(4):447-456.
5. Rokholm B, Baker JL, Sørensen TI. The levelling off of the obesity epidemic since the year 1999-A review of evidence and perspectives. Obes Rev. 2010;11(12):835-846.
6. Warensjö E, Sundström J, Lind L, et al. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr. 2006;84(2):442-448.
7. Phillips CM, Goumidi L, Bertrais S, et al. Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J Nutr. 2010;140(2):238-244.
8. Carpentier YA, Portois L, Malaisse WJ. n-3 fatty acids and the metabolic syndrome. Am J Clin Nutr. 2006;83(6 suppl): 1499S-1504S.
9. Simopoulos AP, Leaf A, Salem N Jr. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab. 1999;43(2):127-130.
10. Hibbeln JR, Nieminen LR, Blasbalg TL, et al. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006;83(6 suppl): 1483S-1493S.
11. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008;233(6):674-688.
12. Fedor D, Kelley DS. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care. 2009;12(2):138-146.
13. Lovejoy JC, Smith SR, Champagne CM, et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care. 2002;25(8):1283-1288.
14. Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA. 2004;292(12):1440-1446.
15. Brady LM, Williams CM, Lovegrove JA. Dietary PUFA and the metabolic syndrome in Indian Asians living in the UK. Proc Nutr Soc. 2004;63(1):115-125.
16. Soininen P, Kangas AJ, Würtz P, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134(9):1781-1785.
17. Tukiainen T, Tynkkynen T, Mäkinen VP, et al. A multimetabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease. Biochem Biophys Res Commun. 2008;375(3):356-361.
18. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645.
19. Ahonen TM, Saltevo JT, Kautiainen HJ, et al. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2012;22(3):285-291.
20. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47(5):348-380.
21. Bot M, Spijkerman AM, Twisk JW, et al. Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort. Eur J Epidemiol. 2010;25(2): 125-133.
22. Lloyd-Jones DM, Liu K, Colangelo LA, et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: The Coronary Artery Risk Development in Young Adults Study. Circulation. 2007;115(8):1004-1011.
23. Carnethon MR, Loria CM, Hill JO, et al. Risk factors for the metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, 1985-2001. Diabetes Care. 2004;27(11):2707-2715.
24. Baik I, Abbott RD, Curb JD, et al. Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc. 2010;110(7):1018-1026.
25. Galan P, Kesse-Guyot E, Czernichow S, et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: A randomised placebo controlled trial. SU.FOL.OM3 Collaborative Group. BMJ. 2010;341:c6273. (doi:10.1136/bmj. c6273).
26. Folsom AR, Demissie Z. Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women. Am J Epidemiol. 2004;160(10):1005-1010.
27. Kaushik M, Mozaffarian D, Spiegelman D, et al. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr. 2009;90(3):613-620.
28. Pietinen P, Paturi M, Reinivuo H, et al. FINDIET 2007 Survey: energy and nutrient intakes. Public Health Nutr. 2010;13(6A):920-924.
29. Hamazaki T, Okuyama H. The Japan Society for Lipid Nutrition recommends to reduce the intake of linoleic acid. A review and critique of the scientific evidence. World Rev Nutr Diet. 2003;92:109-132.
30. Stettler R, Ith M, Acheson KJ, et al. Interaction between dietary lipids and physical inactivity on insulin sensitivity and on intramyocellular lipids in healthy men. Diabetes Care. 2005;28(6):1404-1409.
31. Kumanyika SK, Obarzanek E, Stettler N, et al. Populationbased prevention of obesity: The need for comprehensive promotion of healthful eating, physical activity, and energy balance: A scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the Expert Panel on Population and Prevention Science). Circulation. 2008;118(4):428-464.
32. Hernández-Morante JJ, Larqué E, Luján JA, et al. N-6 from different sources protects from metabolic alterations to obese patients: A factor analysis. Obesity (Silver Spring). 2009;17(3):452-459.
33. Salmerón J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001; 73(6):1019-1026.
34. Galgani JE, Uauy RD, Aguirre CA, et al. Effect of the dietary fat quality on insulin sensitivity. Br J Nutr. 2008;100(3):471-479.
35. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med. 1999;246(4):341-355.
36. Williams CM. Dietary interventions affecting chylomicron and chylomicron remnant clearance. Atherosclerosis. 1998;141(suppl 1):S87-S92.
37. Harris WS, Mozaffarian D, Rimm E, et al. Omega-6 fatty acids and risk for cardiovascular disease: A science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009;119(6):902-907.